You have 9 free searches left this month | for more free features.

Vasoactive Intestinal Peptide

Showing 1 - 25 of 5,817

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Sepsis, Respiratory Distress Syndrome, Respiratory Distress Syndrome, Adult Trial in Northport, Stony Brook (vasoactive

Completed
  • Sepsis
  • +2 more
  • vasoactive intestinal peptide
  • Northport, New York
  • +1 more
May 3, 2022

Migraine, Pain, Neurologic Manifestations Trial in Glostrup (Vasoactive Intestinal Polypeptide (VIP), Sterile saline)

Completed
  • Migraine
  • +5 more
  • Vasoactive Intestinal Polypeptide (VIP)
  • Sterile saline
  • Glostrup, Copenhagen, Denmark
    Danish Headache Center
Oct 19, 2020

Headache Disorders Trial in København S (Vasoactive Intestinal Peptide (VIP) and Saline)

Completed
  • Headache Disorders
  • Vasoactive Intestinal Peptide (VIP) and Saline
  • København S, Danmark, Denmark
    Danish headache center
Aug 19, 2020

Critical COVID-19 With Respiratory Failure Trial in United States (ZYESAMI (aviptadil acetate))

No longer available
  • Critical COVID-19 With Respiratory Failure
  • ZYESAMI (aviptadil acetate)
  • Gilbert, Arizona
  • +24 more
Jul 19, 2022

Pulmonary Arterial Hypertension Trial in United States (Pemziviptadil (PB1046))

Terminated
  • Pulmonary Arterial Hypertension
  • Pemziviptadil (PB1046)
  • Mobile, Alabama
  • +25 more
Feb 4, 2022

SARS-CoV 2, COVID, ARDS Trial (ZYESAMI™ (aviptadil acetate), Placebo, Nebulized administration of ZYESAMI™ or Placebo)

Withdrawn
  • SARS-CoV 2
  • +5 more
  • ZYESAMI™ (aviptadil acetate)
  • +2 more
  • (no location specified)
Feb 2, 2023

Digestive System Neuroendocrine Tumor G1, Digestive System Neuroendocrine Tumor G2, Metastatic Digestive System Neuroendocrine

Not yet recruiting
  • Digestive System Neuroendocrine Tumor G1
  • +5 more
  • Tumor Debulking
  • +5 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Aug 23, 2023

SARS-CoV 2, COVID, ARDS Trial in United States (ZYESAMI™ (aviptadil acetate), Placebo, Nebulized administration of ZYESAMI™ or

Terminated
  • SARS-CoV 2
  • +5 more
  • ZYESAMI™ (aviptadil acetate)
  • +2 more
  • Fullerton, California
  • +12 more
Feb 2, 2023

Covid19 Trial in Brazil, United States (Remdesivir, Remdesivir Placebo, Aviptadil)

Completed
  • Covid19
  • Remdesivir
  • +4 more
  • Tucson, Arizona
  • +39 more
Dec 16, 2022

Pulmonary Arterial Hypertension Trial in Columbus, Pittsburgh (PB1046 Subcutaneous Injection)

Completed
  • Pulmonary Arterial Hypertension
  • PB1046 Subcutaneous Injection
  • Columbus, Ohio
  • +1 more
Oct 7, 2019

Trigeminal Neuralgia Trial (trigminal nerve block with RFT)

Not yet recruiting
  • Trigeminal Neuralgia
  • trigminal nerve block with RFT
  • (no location specified)
Jan 29, 2023

Transcutaneous Electrical Acupoint Stimulation Trial (transcutaneous electrical acupoint stimulation)

Not yet recruiting
  • Transcutaneous Electrical Acupoint Stimulation
  • transcutaneous electrical acupoint stimulation
  • (no location specified)
May 17, 2022

Blood Flow Trial in Copenhagen (GIPR antagonist / study tool, GLP-2R antagonist / study tool, Placebo)

Recruiting
  • Blood Flow
  • GIPR antagonist / study tool
  • +2 more
  • Copenhagen, Denmark
    Rigshospitalet
Nov 2, 2022

Patients With Polycystic Ovary Syndrome (PCOS)

Recruiting
  • Polycystic Ovary Syndrome
  • Ovary Biopsie
  • Tirana, Albania
    University of medicine of Tirana
Jul 28, 2023

Gastroenteropancreatic Neuroendocrine Tumor Trial in Stanford (Lutathera, Gallium 68 Dotatate, Computed Tomography (CT))

Suspended
  • Gastroenteropancreatic Neuroendocrine Tumor
  • Stanford, California
    Stanford Cancer Institute Palo Alto
Sep 21, 2022

Critical COVID-19 With Respiratory Failure, Acute Respiratory Distress Syndrome (ARDS), Corona Virus Infection Trial in United

Completed
  • Critical COVID-19 With Respiratory Failure
  • +3 more
  • Aviptadil by intravenous infusion + standard of care
  • Normal Saline Infusion + standard of care
  • Fullerton, California
  • +9 more
Sep 5, 2021

Neuropeptides and Venous Pelvic Pain

Active, not recruiting
  • Pelvic Pain
  • +2 more
    • Moscow, Russian Federation
      Department of Faculty Surgery №1
    Sep 20, 2021

    Sars-CoV-2 Infection Trial in São Paulo, Guarulhos (Analysis of genetic polymorphisms of vasoactive peptides in COVID-19)

    Not yet recruiting
    • Sars-CoV-2 Infection
    • Analysis of genetic polymorphisms of vasoactive peptides in COVID-19
    • São Paulo, Sao Paulo, Brazil
    • +1 more
    Dec 14, 2021

    Type 2 Diabetes, Obesity Trial in Turku (Roux-en-Y, GIP-infusion, GLP-1)

    Completed
    • Type 2 Diabetes
    • Obesity
    • Roux-en-Y
    • +4 more
    • Turku, Finland
      Turku univercity hospital, PET center
    Oct 12, 2021

    Seasonal Allergic Rhinitis Trial in Beijing (SPA acupuncture, sham acupuncture)

    Recruiting
    • Seasonal Allergic Rhinitis
    • SPA acupuncture
    • sham acupuncture
    • Beijing, Beijing, China
      Hongfei Lou
    Aug 19, 2022

    COVID-19 Trial in Atlanta (Duvelisib, Placebo)

    Completed
    • COVID-19
    • Atlanta, Georgia
    • +2 more
    Jun 10, 2022

    Postural Tachycardia Syndrome (POTS) Trial in Nashville (Measurement of Splanchnic venous capacitance(SVC))

    Not yet recruiting
    • Postural Tachycardia Syndrome (POTS)
    • Measurement of Splanchnic venous capacitance(SVC)
    • Nashville, Tennessee
      Vanderbilt University Medical Center
    Dec 8, 2022

    Cerebral Palsy Trial in Amersham, Brighton, Manchester (Paediatric Formula)

    Completed
    • Cerebral Palsy
    • Paediatric Formula
    • Amersham, United Kingdom
    • +2 more
    Aug 17, 2020

    New Persistent Daily Headache Trial (CGRP antibody)

    Not yet recruiting
    • New Persistent Daily Headache
    • CGRP antibody
    • (no location specified)
    Aug 29, 2023

    Allergic Rhinitis Trial in Beijing (AIT drops, Clarityne, Rhinocort and Emedastine Difumarate Eye Drops)

    Recruiting
    • Allergic Rhinitis
    • AIT drops
    • Clarityne, Rhinocort and Emedastine Difumarate Eye Drops
    • Beijing, China
    • +2 more
    May 21, 2022